Fractional support might sound like a finance term, but in biotech it is simple. You get experienced marketing and business development professionals working as part of your team without the cost of hiring them full time. This is not about an agency assigning a junior account manager who has to Google what “CMC” means. It is senior-level strategic input built into your weekly rhythm. We join your calls, review your data, and understand your timelines, scientific nuance, and how to translate it into messages that pharma partners and investors value.
Think of it as having a commercial team that is flexible, embedded, and fluent in biotech without committing to full time salaries before you are ready. That is fractional done right.
Why Fractional Support Matters in Biotech
Our approach to life sciences business development is built for the realities of biotech. Biotech is not SaaS. You are navigating clinical milestones, regulatory hurdles, long fundraising cycles, and buyer journeys that can take 12 to 24 months. Marketing and business development in biotech cannot be superficial. You need more than a website or a basic lead generation funnel. You need a strategy that adapts when a Q1 milestone delay shifts your outreach plan, and you need to see a scientific poster as a commercial asset, not just content.
Many agencies miss this. They reuse generic templates and add biotech buzzwords. A fractional biotech marketing and BD team is different. We adapt with you. We adjust when your data readout changes. We build systems that grow with your company and create stories that stand up to scientific, financial, and regulatory scrutiny.
How Fractional Marketing and BD Works
It starts with your positioning. Not vague “revolutionize X” statements, but a sharp value proposition that convinces VCs, pharma scouts, and advisors. We ask hard questions and refine your story until it clicks.
From there, we get tactical. That might mean:
-
Rewriting your pitch deck to sound investor ready, not like a grant application
-
Creating a lean, effective biotech website
-
Turning data into commercial assets: one-pagers, posts, PDFs
-
Planning conference strategies: who to meet, how to follow up, and what to bring
-
Running business development outreach to get you in front of the right partners
And we stay involved, updating strategies when protocols change, joining calls before key meetings, and advising on whether to prioritize partnering or visibility.
Case Study: From Invisible to In-Demand
An early-stage oncology biotech had strong preclinical data but no commercial traction. Within eight weeks of fractional support:
-
Week 1: Core narrative rewritten
-
Week 2: Landing page and teaser deck built for BD partners
-
Week 3: Targeted outreach to 15 curated companies
-
Week 8: Three active conversations, one LoI, and two new VC introductions
This happened because biotech expertise met commercial execution without the cost of a full time team.
Who Benefits from Fractional Marketing and BD
This model works for biotech companies that are:
-
Preclinical or early clinical, needing visibility and credibility without a full team
-
Funded but time poor, where the science moves fast and the commercial side must keep up
-
Preparing for a raise or partnerships and needing investor ready materials
-
Frustrated with agencies that do not understand regulatory or scientific context
It is not for companies wanting a quick campaign without strategy or expecting results without collaboration.
The Bottom Line
Biotech founders do not have time for marketing fluff or BD theater. You need clarity, speed, and alignment with your scientific goals. Fractional marketing and business development in biotech brings senior-level execution embedded in your company, driving real outcomes.
We are not an agency. We are not consultants. We are your commercial team until you have the bench strength to hire your own. And when that day comes, we will help you build it.
